Key result
Amniotic membrane plus mononuclear stem cells reduces ventricular volumes and myocardial fibrosis after MI.
Why the study?
Loss of cardiomyocytes and fibrotic scarring after acute myocardial infarction lead to heart failure, prompting the evaluation of regenerative strategies using stem cells and amniotic membrane.
Does the combination of human amniotic membrane and mononuclear stem cells improve ventricular remodeling in a rat model of acute myocardial infarction with left ventricular dysfunction?
RCT (n=120)
Randomized
Does the combination of human amniotic membrane and mononuclear stem cells improve ventricular remodeling in a rat model of acute myocardial infarction with left ventricular dysfunction?
The combination of human amniotic membrane and mononuclear stem cells promotes favorable ventricular remodeling and reduces fibrosis in a rat model of acute myocardial infarction.
Hypothesis-generating for combined amniotic membrane-stem cell therapy in post-MI remodeling; leaves open translation to human trials.
Acute myocardial infarction (AMI) results from a lack of oxygen supply to the myocardium, leading to the loss of cardiomyocytes and their replacement with fibrotic scar tissue. This process is closely associated with the development of heart failure. Regenerative medicine has emerged as a promising strategy to enhance treatment outcomes in severe cases of heart failure. This study aimed to evaluate myocardial regeneration after AMI using a biomaterial composed of mononuclear stem cells and human amniotic membrane. A total of 120 Wistar rats were subjected to experimentally induced AMI. On the 7th day post-infarction, rats with an ejection fraction of <50% on echocardiography were randomized into four groups: (1) control; (2) stem cells; (3) amniotic membrane; and (4) amniotic membrane combined with stem cells. On the 30th day, the surviving animals underwent a second echocardiographic evaluation and were subsequently euthanized. The group treated with the combination of amniotic membrane and stem cells showed reduced systolic and diastolic ventricular volumes. Histological analysis revealed that these animals exhibited less fibrosis and a lower percentage of type I collagen. Based on the results of the study, it was concluded that the combination of human amniotic membrane and mononuclear stem cells decreased ventricular volumes and myocardial fibrosis, suggesting more favorable ventricular remodeling in this experimental model.
No takes yet. Share an insight, caveat, or question.
Rossa et al. (2026) conducted an RCT in Acute myocardial infarction with left ventricular dysfunction (n=120). Amniotic membrane combined with mononuclear stem cells vs. Control, stem cells alone, or amniotic membrane alone was evaluated on Ventricular volumes and myocardial fibrosis. The combination of human amniotic membrane and mononuclear stem cells decreased systolic and diastolic ventricular volumes and reduced myocardial fibrosis in rats with acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: